Press release
United States Diabetes Care Drugs & Devices Market is to reach US$ 244.46 billion by 2033 - Driven by Rising Diabetes Prevalence, Technological Innovations, and Increasing Healthcare Investments | DataM Intelligence
Diabetes Care Drugs & Devices Market
Download Free sample report:-https://www.datamintelligence.com/download-sample/diabetes-care-drugs-and-devices-market?pratik
Recent Industry Development in U.S market:
✅ The U.S. diabetes care drugs & devices market is projected to grow from US$ 62.52 billion in 2025 to US$ 76.15 billion by 2030, at a CAGR of 4.02%.
✅ The U.S. diabetes devices market was about US$ 9.53 billion in 2023, and is expected to reach US$ 15.22 billion by 2030, growing at a CAGR of 6.9% (2024-2030).
✅ Medicare's wider CGM coverage and FDA approvals are lowering access barriers, especially for type-2 diabetes patients who previously relied on finger-stick tests.
✅ Regulatory innovation: Dexcom's G7 15-day CGM system recently received FDA clearance, which is significant because it's one of the longest-wear CGM devices, enhancing convenience for users.
✅ Spending on GLP-1 drugs (used both for diabetes and obesity) is surging: U.S. adult usage of GLP-1s has increased, and Medicare Part D spending on diabetes drugs (including GLP-1s) quadrupled from 2019 to 2023.
✅ Cost-pressure and access initiatives: Several policy and commercial moves are underway to make diabetes drugs more affordable ( GLP-1 pricing debates, PBM formulary shifts), which could reshape how patients access both drugs and devices
Recent Industry Development in Japan market:
✅ Japan's diabetes drugs & devices market is estimated at US$ 4.95 billion in 2025, growing to US$ 5.80 billion by 2030, with a CAGR of 3.2%.
✅ The Japan diabetes devices market is projected to grow strongly: it was USD 1,547.0 million in 2023 and is expected to reach USD 2,913.3 million by 2030 (CAGR 9.5%).
✅ In Japan, insulin delivery devices are the dominant device segment, and within that, insulin pumps are notably growing.
✅ The insulin pump sub-market in Japan is seeing rapid growth: it generated US$ 308.1 million in 2024 and is forecast to reach US$ 545.9 million by 2030 (CAGR 9.8%).
✅ There is increasing adoption of connected therapeutic devices, such as smart insulin pens and automated pumps, in Japan.
✅ On the monitoring side, continuous glucose monitoring (CGM) systems are rising in use: this is driven by more favorable reimbursement and adoption in clinical practice in Japan.
Key Investment
➠ Insulet Corporation (U.S.): Acquired insulin pump IP from Bigfoot Biomedical in February 2023 for USD 25 million, strengthening its AID (automated insulin delivery) technology capabilities.
➠ Glooko, Inc. (U.S.): Raised USD 100 million in a Series F financing round in October 2024, led by Georgian and other investors, to scale its digital diabetes management platform globally.
➠ Modular Medical, Inc. (U.S.): Received FDA clearance for its MODD1 insulin patch pump in September 2024; commercial launch is expected in early 2025.
➠ In November 2025, Modular Medical submitted its next-gen Pivot tubeless patch pump to FDA (510(k)), aiming to target a USD 3 billion "almost-pumper" segment.
Benefits of AI for the Diabetes Care Drugs & Devices Market
➠Improved glucose monitoring accuracy through AI-driven predictive algorithms in CGMs and smart glucometers.
➠Personalized insulin dosing using AI-powered insulin pumps and decision-support systems.
➠Early detection of hypoglycemia and hyperglycemia using real-time AI alerts and pattern recognition.
➠Enhanced drug effectiveness analysis with AI analyzing patient response data for optimized therapies.
➠Automation of data logging, reducing manual tracking for patients and clinicians.
➠Predictive disease progression modeling to support timely treatment adjustments.
➠Smarter wearable devices with AI-enabled insights for lifestyle, diet, and activity management.
➠Improved telemedicine outcomes using AI-assisted remote monitoring and virtual diabetes care.
➠Supply chain optimization for diabetes drugs and devices using AI-based demand forecasting.
➠Better regulatory compliance with AI ensuring accurate reporting, device performance tracking, and safety monitoring.
"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=diabetes-care-drugs-and-devices-market?pratik ((Purchase 2 or more Repots and get 50% Discount)
Segmentation Analysis :
➠By Product Type:
Diabetes devices and diabetes drugs together shape the market landscape, with devices gaining traction due to rising adoption of CGM, insulin pumps, and digital monitoring tools. Diabetes drugs remain essential, led by insulin therapies, GLP-1 agonists, SGLT-2 inhibitors, and combination drugs.
➠By Application:
Type 2 diabetes dominates market share owing to its growing global prevalence and expanding patient pool. Type 1 diabetes remains a stable segment driven by lifelong insulin demand. Gestational diabetes and prediabetes are rapidly growing categories supported by expanding screening programs and preventive care initiatives.
➠By End-User:
Hospitals lead usage due to high patient inflow and advanced treatment capabilities. Specialty clinics hold significant share for chronic diabetes management. Homecare settings are expanding fast, driven by self-monitoring devices and home-based insulin delivery. Diagnostic centers contribute steadily through routine testing and diabetes screening services.
Regional Insights:
➠North America: Largest market roughly 38% of diabetes devices/drugs revenue (North American diabetes devices market held about 38.7% share in 2023). Growth is powered by high healthcare spending, widespread adoption of continuous glucose monitors (CGMs) and insulin pumps
➠Asia-Pacific: Fastest-growing region high single-digit CAGRs reported (examples: 7.6% CAGR in APAC device market forecasts), driven by rising diabetes prevalence, large undiagnosed populations, government healthcare modernization and screening programs in China/India/Japan, growing affordability.
➠Europe: Mature, steady market with moderate growth focus on regulatory compliance, health-technology assessment and value-based procurement. Market expansion is steadied by strong clinical adoption in Western Europe, growing emphasis on integrated care pathways and digital diabetes management
Growth drivers:
Rising prevalence of diabetes globally, with increasing patient numbers projected to grow significantly by 2030 and beyond.
Technological advancements in diabetes care devices, including continuous glucose monitoring, smart insulin pumps, and non-invasive glucose monitoring.
Increasing awareness and demand for diabetes management and early diagnosis.
Expansion of healthcare infrastructure and improving access to advanced diabetes care in emerging markets.
Increasing obesity rates, sedentary lifestyles, and unhealthy diets contributing to the rise in Type 2 diabetes cases.
Government initiatives, favorable reimbursement policies, and increased investments toward diabetes care.
Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/diabetes-care-drugs-and-devices-market?pratik
Key players:
F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Merck & Co., Inc., Novo Nordisk A/S., Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals, Inc and Insulet Corporation.
Key highlights:
➠ F. Hoffmann-La Roche Ltd
Global leader in diabetes diagnostics, especially glucose monitoring systems and insulin delivery solutions. Strong R&D capabilities and continuous product upgrades-such as connected glucose meters-solidify its dominance across North America and Europe.
➠ Abbott Laboratories
Front-runner in continuous glucose monitoring (CGM) with its FreeStyle Libre platform. Known for user-friendly, sensor-based monitoring technologies that reduce finger-pricking, Abbott drives rapid market expansion in both developed and emerging regions.
➠ Medtronic plc
Major innovator in insulin pump technologies and hybrid closed-loop systems. Its automated insulin delivery solutions strengthen its leadership in advanced diabetes management, especially within hospital and homecare settings worldwide.
➠ Terumo Corporation
Key player in insulin syringes, pen needles, and infusion sets. Terumo's precision-engineered devices and strong presence in Asia position it as a critical provider of safe, reliable diabetes care consumables.
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Diabetes Care Drugs & Devices Market is to reach US$ 244.46 billion by 2033 - Driven by Rising Diabetes Prevalence, Technological Innovations, and Increasing Healthcare Investments | DataM Intelligence here
News-ID: 4279469 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
U.S. Diagnostic Dermatology Equipment Market to Reach USD 3.06 Billion by 2030, …
The U.S. Diagnostic Dermatology Equipment Market was valued at US$ 1.84 billion in 2024 and is projected to reach US$ 3.06 billion by 2030, growing at a CAGR of 9% during the forecast period.
The market maintains a strong position in the U.S. healthcare landscape, driven by the rising prevalence of skin cancers, chronic skin conditions, and increasing demand for early and accurate diagnosis. Growth is supported by continuous advancements in…
US Bioactive Wound Care Market Projected to Grow at 7.7% CAGR by 2032, Supported …
Leander, Texas and TOKYO, Japan - The United States Bioactive Wound Care Market is valued at approximately USD 12.54 billion in 2025 and is projected to reach about USD 21.18 billion by 2032, growing at a CAGR of around 7.7% during this period.
This rapid growth reflects increasing adoption of advanced wound healing technologies, an aging population, and rising prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and…
United States Aquaculture vaccines market is growing with a CAGR of 9% - Driven …
The global Aquaculture vaccines market is valued at about USD 400-500 million and is set to more than double by 2030-2034, growing at a strong 9% CAGR.
The market is growing due to rising fish farming, disease outbreaks, demand for antibiotic-free seafood, and advances in vaccine tech.
Download Free sample report:-https://www.datamintelligence.com/download-sample/aquaculture-vaccines-market?pratik
Recent Industry Development in U.S market:
✅ The U.S. aquaculture vaccines market generated USD 62.4 million in 2023, and is projected to…
U.S. External and Implantable Cardiac Defibrillators Market to Reach USD 4.32 Bi …
The U.S. External and Implantable Cardiac Defibrillators Market was valued at US$ 2.64 billion in 2023 and is projected to reach US$ 4.32 billion by 2030, growing at a CAGR of 7.3% during 2024-2030. Market expansion is supported by the rising prevalence of sudden cardiac arrest, growing adoption of advanced defibrillation technologies, and increased deployment of external defibrillators across hospitals, public facilities, and emergency response systems.
The market holds a strong…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
